Banks
Build Your Comparison
Side-by-side financial analysisStock Comparison
CBK vs HOMB vs SFNC vs IBCP vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Diversified
CBK vs HOMB vs SFNC vs IBCP vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Diversified |
| Market Cap | $422M | $5.58B | $3.27B | $730M | $896.00B |
| Revenue (TTM) | $129M | $1.37B | $618M | $310M | $280.33B |
| Net Income (TTM) | $38M | $475M | $-398M | $69M | $57.05B |
| Gross Margin | 69.8% | 77.3% | 4.5% | 69.1% | 60.0% |
| Operating Margin | 37.5% | 43.8% | -85.4% | 26.2% | 25.9% |
| Forward P/E | 10.5x | 11.5x | 10.9x | 10.0x | 14.4x |
| Total Debt | $167M | $935M | $641M | $117M | $942.38B |
| Cash & Equiv. | $0.00 | $667M | $380M | $52M | $343.34B |
CBK vs HOMB vs SFNC vs IBCP vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Home Bancshares, In… (HOMB) | 100 | 183.7 | +83.7% |
| Simmons First Natio… (SFNC) | 100 | 131.6 | +31.6% |
| Independent Bank Co… (IBCP) | 100 | 238.9 | +138.9% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CBK vs HOMB vs SFNC vs IBCP vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CBK carries the broadest edge in this set and is the clearest fit for sleep-well-at-night.
- Lower volatility, beta 0.50, Low D/E 58.5%, current ratio 0.14x
- Efficiency ratio 0.3% vs SFNC's 0.9% (lower = leaner)
- Beta 0.50 vs JPM's 0.94, lower leverage
- Efficiency ratio 0.3% vs SFNC's 0.9%
HOMB is the clearest fit if your priority is income & stability and bank quality.
- Dividend streak 15 yrs, beta 0.66, yield 2.8%
- NIM 3.8% vs JPM's 2.2%
SFNC is the #2 pick in this set and the best alternative if value and dividends is your priority.
- Lower P/E (10.9x vs 11.5x)
- 3.8% yield, 14-year raise streak, vs HOMB's 2.8%
- +23.0% vs HOMB's +3.0%
IBCP is the clearest fit if your priority is defensive.
- Beta 0.72, yield 2.9%, current ratio 370.62x
JPM ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 3.3%, EPS growth 1.5%
- 465.8% 10Y total return vs IBCP's 194.4%
- PEG 0.81 vs IBCP's 1.90
- 3.3% NII/revenue growth vs SFNC's -56.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.3% NII/revenue growth vs SFNC's -56.7% | |
| Value | Lower P/E (10.9x vs 11.5x) | |
| Quality / Margins | Efficiency ratio 0.3% vs SFNC's 0.9% (lower = leaner) | |
| Stability / Safety | Beta 0.50 vs JPM's 0.94, lower leverage | |
| Dividends | 3.8% yield, 14-year raise streak, vs HOMB's 2.8% | |
| Momentum (1Y) | +23.0% vs HOMB's +3.0% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs SFNC's 0.9% |
CBK vs HOMB vs SFNC vs IBCP vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CBK vs HOMB vs SFNC vs IBCP vs JPM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HOMB leads in 1 of 6 categories
SFNC leads 1 • IBCP leads 1 • JPM leads 1 • CBK leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HOMB leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 2170.6x CBK's $129M. HOMB is the more profitable business, keeping 34.6% of every revenue dollar as net income compared to SFNC's -64.3%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $129M | $1.4B | $618M | $310M | $280.3B |
| EBITDAEarnings before interest/tax | $50M | $618M | -$444M | $89M | $81.4B |
| Net IncomeAfter-tax profit | $38M | $475M | -$398M | $69M | $57.0B |
| Free Cash FlowCash after capex | $37M | $311M | $410M | $70M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +69.8% | +77.3% | +4.5% | +69.1% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +37.5% | +43.8% | -85.4% | +26.2% | +25.9% |
| Net MarginNet income ÷ Revenue | +29.3% | +34.6% | -64.3% | +22.1% | +20.4% |
| FCF MarginFCF ÷ Revenue | +28.4% | +22.6% | +66.4% | +22.6% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +6.1% | +26.0% | +42.1% | +2.3% | +16.0% |
Valuation Metrics
SFNC leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 10.5x trailing earnings, CBK trades at a 34% valuation discount to JPM's 16.0x P/E. Adjusting for growth (PEG ratio), HOMB offers better value at 0.89x vs IBCP's 2.06x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $422M | $5.6B | $3.3B | $730M | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $589M | $5.9B | $3.5B | $795M | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 10.54x | 11.72x | -7.63x | 10.85x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.51x | 11.47x | 10.90x | 9.99x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.89x | — | 2.06x | 0.90x |
| EV / EBITDAEnterprise value multiple | 11.88x | 9.47x | — | 9.78x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 3.21x | 4.06x | 5.21x | 2.32x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.49x | 1.30x | 0.89x | 1.47x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 11.97x | 11.58x | 7.73x | 10.41x | 8.88x |
Profitability & Efficiency
IBCP leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-11 for SFNC. SFNC carries lower financial leverage with a 0.19x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), IBCP scores 8/9 vs SFNC's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +14.3% | +11.4% | -11.5% | +14.2% | +15.9% |
| ROA (TTM)Return on assets | +1.7% | +2.1% | -1.6% | +1.3% | +1.3% |
| ROICReturn on invested capital | +9.1% | +8.7% | -9.1% | +10.2% | +4.5% |
| ROCEReturn on capital employed | +5.8% | +11.5% | -4.2% | +2.6% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 4 | 8 | 5 |
| Debt / EquityFinancial leverage | 0.59x | 0.22x | 0.19x | 0.23x | 2.60x |
| Net DebtTotal debt minus cash | $167M | $268M | $261M | $65M | $599.0B |
| Cash & Equiv.Liquid assets | $0 | $667M | $380M | $52M | $343.3B |
| Total DebtShort + long-term debt | $167M | $935M | $641M | $117M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 1.25x | 1.47x | -1.01x | 0.91x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $8,847 for SFNC. Over the past 12 months, SFNC leads with a +23.0% total return vs HOMB's +3.0%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs CBK's 6.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +21.6% | +2.7% | +20.7% | +12.0% | -0.5% |
| 1-Year ReturnPast 12 months | +21.6% | +3.0% | +23.0% | +16.4% | +21.8% |
| 3-Year ReturnCumulative with dividends | +21.6% | +31.2% | +37.1% | +110.4% | +138.2% |
| 5-Year ReturnCumulative with dividends | +21.6% | +22.1% | -11.5% | +80.9% | +118.2% |
| 10-Year ReturnCumulative with dividends | +21.6% | +57.7% | +26.2% | +194.4% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +6.7% | +9.5% | +11.1% | +28.1% | +33.6% |
Risk & Volatility
Evenly matched — CBK and SFNC each lead in 1 of 2 comparable metrics.
Risk & Volatility
CBK is the less volatile stock with a 0.50 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SFNC currently trades 99.5% from its 52-week high vs IBCP's 90.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.50x | 0.66x | 0.89x | 0.72x | 0.94x |
| 52-Week HighHighest price in past year | $31.67 | $30.83 | $22.62 | $39.16 | $337.25 |
| 52-Week LowLowest price in past year | $24.32 | $25.50 | $17.00 | $29.63 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +97.2% | +91.6% | +99.5% | +90.6% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 66.3 | 63.7 | 63.7 | 61.2 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 55K | 1.4M | 1.1M | 135K | 7.0M |
Analyst Outlook
Evenly matched — HOMB and SFNC and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HOMB as "Hold", SFNC as "Buy", IBCP as "Hold", JPM as "Buy". Consensus price targets imply 11.5% upside for HOMB (target: $32) vs 2.2% for SFNC (target: $23). For income investors, SFNC offers the higher dividend yield at 3.79% vs CBK's 0.47%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $31.50 | $23.00 | $38.00 | $339.75 |
| # AnalystsCovering analysts | — | 19 | 9 | 7 | 61 |
| Dividend YieldAnnual dividend ÷ price | +0.5% | +2.8% | +3.8% | +2.9% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 15 | 14 | 11 | 15 |
| Dividend / ShareAnnual DPS | $0.14 | $0.80 | $0.85 | $1.03 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +1.5% | 0.0% | +1.7% | +3.9% |
HOMB leads in 1 of 6 categories (Income & Cash Flow). SFNC leads in 1 (Valuation Metrics). 2 tied.
CBK vs HOMB vs SFNC vs IBCP vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CBK or HOMB or SFNC or IBCP or JPM a better buy right now?
For growth investors, JPMorgan Chase & Co.
(JPM) is the stronger pick with 3. 3% revenue growth year-over-year, versus -56. 7% for Simmons First National Corporation (SFNC). Commercial Bancgroup, Inc. Common Stock (CBK) offers the better valuation at 10. 5x trailing P/E (10. 5x forward), making it the more compelling value choice. Analysts rate Simmons First National Corporation (SFNC) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CBK or HOMB or SFNC or IBCP or JPM?
On trailing P/E, Commercial Bancgroup, Inc.
Common Stock (CBK) is the cheapest at 10. 5x versus JPMorgan Chase & Co. at 16. 0x. On forward P/E, Independent Bank Corporation is actually cheaper at 10. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Independent Bank Corporation's 1. 90x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CBK or HOMB or SFNC or IBCP or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to -11. 5% for Simmons First National Corporation (SFNC). Over 10 years, the gap is even starker: JPM returned +465. 8% versus CBK's +21. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CBK or HOMB or SFNC or IBCP or JPM?
By beta (market sensitivity over 5 years), Commercial Bancgroup, Inc.
Common Stock (CBK) is the lower-risk stock at 0. 50β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 88% more volatile than CBK relative to the S&P 500. On balance sheet safety, Simmons First National Corporation (SFNC) carries a lower debt/equity ratio of 19% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — CBK or HOMB or SFNC or IBCP or JPM?
By revenue growth (latest reported year), JPMorgan Chase & Co.
(JPM) is pulling ahead at 3. 3% versus -56. 7% for Simmons First National Corporation (SFNC). On earnings-per-share growth, the picture is similar: Home Bancshares, Inc. grew EPS 19. 9% year-over-year, compared to -343. 8% for Simmons First National Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CBK or HOMB or SFNC or IBCP or JPM?
Home Bancshares, Inc.
(HOMB) is the more profitable company, earning 34. 6% net margin versus -63. 4% for Simmons First National Corporation — meaning it keeps 34. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HOMB leads at 43. 8% versus -84. 2% for SFNC. At the gross margin level — before operating expenses — HOMB leads at 77. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CBK or HOMB or SFNC or IBCP or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Independent Bank Corporation's 1. 90x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Independent Bank Corporation (IBCP) trades at 10. 0x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 4. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HOMB: 11. 5% to $31. 50.
08Which pays a better dividend — CBK or HOMB or SFNC or IBCP or JPM?
All stocks in this comparison pay dividends.
Simmons First National Corporation (SFNC) offers the highest yield at 3. 8%, versus 0. 5% for Commercial Bancgroup, Inc. Common Stock (CBK).
09Is CBK or HOMB or SFNC or IBCP or JPM better for a retirement portfolio?
For long-horizon retirement investors, Independent Bank Corporation (IBCP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
72), 2. 9% yield, +194. 4% 10Y return). Both have compounded well over 10 years (IBCP: +194. 4%, CBK: +21. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CBK and HOMB and SFNC and IBCP and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CBK is a small-cap deep-value stock; HOMB is a small-cap deep-value stock; SFNC is a small-cap income-oriented stock; IBCP is a small-cap deep-value stock; JPM is a large-cap deep-value stock. HOMB, SFNC, IBCP, JPM pay a dividend while CBK does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.